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Abstract
Hydra is a unique model for studying the mechanisms underlying stem cell biology. The activity of the three stem cell
lineages structuring its body constantly replenishes mature cells lost due to normal tissue turnover. By a poorly understood
mechanism, stem cells are maintained through self-renewal while concomitantly producing differentiated progeny. In
vertebrates, one of many genes that participate in regulating stem cell homeostasis is the protooncogene c-myc, which has
been recently identified also in Hydra, and found expressed in the interstitial stem cell lineage. In the present paper, by
developing a novel strategy of RNA interference-mediated gene silencing (RNAi) based on an enhanced uptake of small
interfering RNAi (siRNA), we provide molecular and biological evidence for an unexpected function of the Hydra myc gene
(Hymyc1) in the homeostasis of the interstitial stem cell lineage. We found that Hymyc1 inhibition impairs the balance
between stem cell self renewal/differentiation, as shown by the accumulation of stem cell intermediate and terminal
differentiation products in genetically interfered animals. The identical phenotype induced by the 10058-F4 inhibitor, a
disruptor of c-Myc/Max dimerization, demonstrates the specificity of the RNAi approach. We show the kinetic and the
reversible feature of Hymyc1 RNAi, together with the effects displayed on regenerating animals. Our results show the
involvement of Hymyc1 in the control of interstitial stem cell dynamics, provide new clues to decipher the molecular control
of the cell and tissue plasticity in Hydra, and also provide further insights into the complex myc network in higher
organisms. The ability of Hydra cells to uptake double stranded RNA and to trigger a RNAi response lays the foundations of
a comprehensive analysis of the RNAi response in Hydra allowing us to track back in the evolution and the origin of this
process.
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Introduction
Despite its simple body plan and structural anatomy, the
Cnidaria Hydra, a dipoblastic animal at the base of metazoan
evolution, is an excellent model system to investigate the
mechanisms controlling stem cell proliferation and differentiation
and the balance between the two phenomena. While in most of
animals the self-renewing property is confined to one or more
tissues, in Hydra most of the cells continuously divide and are
displaced towards the animal extremities where terminal differen-
tiation occurs before cell loss. The constant growth process
requires a homeostatic regulation within and between different cell
lineages and a steady state of production and loss of cells [1–4].
The polyp is composed of two epithelial layers, an outer ectoderm
and an inner endoderm, shaping a tube-like body, with a single
opening (mouth) at one end and a foot to anchor to a substrate at
the opposite end. Each layer, which is a single cell deep, comprises
a cell lineage. All other cell types are lodged in the interstices
among the epithelial cells of both layers, and are part of the
interstitial cell lineage (see Figure S1). Interstitial cells occur singly
(1 s) or in clusters of 2, 4, 8 and 16 cells (2 s, 4 s, 8 s, 16 s). All
these classes are actively proliferating, with a cell cycle length of
about 1 day [5]. Single interstitial cells or clusters of 2 form
neurons (sensory and ganglion cells) and secretory cells (zymogen
and mucous cells), while clusters of 4, 8 and 16 interstitial cells
(nematoblasts) differentiate different types of nematocytes. Mul-
tipotent interstitial stem cells, which do not differentiate but simply
proliferate, must exist to provide for growth of the interstitial cell
population and to provide a continuing supply of differentiating
nematocytes, nerve cells, gland cells and gametes [6]. Clearly, a
variety of control mechanisms are needed to maintain steady state
levels of mature cells, as well as to stimulate the rapid production
of specific cell types as needed. This might requires the
participation of many factors, including positive and negative
regulators of growth and differentiation, which determine survival,
growth stimulation, growth arrest, differentiation.
In vertebrates, one of many genes that participate in regulating
cell homeostasis is the protooncogene c-myc. The MYC family of
transcription factors controls disparate aspects of cell physiology
including cell growth, cell cycle progression, biosynthetic metab-
olism, and apoptosis [7–9] and, as expected, its deregulated
expression occurs in the majority of human cancers. Recently, in
Hydra magnipapillata,ac-myc homologue (Hymyc1) has been isolated
and fully characterized [10], and by in silico genomic analysis three
additional myc-like or -related genes have been predicted. Among
them, HyMYC1 and HyMYC2 deduced protein sequences
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domains and MYC boxes I to III, and are clearly orthologues of
vertebrate myc, while the predicted proteins of the two others
(HyMYC3 and HyMYC4) present bHLH-Zip domains but are
highly divergent in the N-terminal regions, suggesting myc-related
roles. Hymyc1 is expressed in proliferating fractions of the
interstitial stem cell system, namely single and pairs of interstitial
stem cells, proliferating nematoblasts, gland cells. Recombinant
hybrid proteins between Hymyc1 and viral myc genes displayed, in
assays of cell transformation, oncogenic potential, suggesting
structural and functional conservation of HyMYC1 protein
domains. By contrast, the functional role played in the interstitial
stem cell lineage in Hydra is unknown. To this aim, we have
developed a new RNA interference (RNAi) approach to
downregulate Hymyc1 expression. By using small interfering RNAs
(siRNA) [11] specifically designed to target Hymyc1, we overcome
the main issue of their delivery to target tissues by modifying their
highly negative charge towards positive values. We have previously
shown the capability of Hydra to actively uptake positively charged
nanoparticles suspended in the culture medium [12]. Here we
show that acidic condition enhances the entry of siRNA duplexes
into the polyps triggering the Hydra RNAi response and leading to
specific post transcriptional Hymyc1 inhibition. Under normal
feeding regime and physiological culturing condition, a large scale
screening of RNAi phenotype was possible, while avoiding
previously used invasive delivering methods to alter gene
expression, such as electroporation [13–15]. We provide molec-
ular evidence of Hymyc1 reduced expression level, while analysis at
cellular level led to decipher an unexpected function in the
homeostasis of interstitial stem cells. Hymyc1 inhibition impairs the
balance between stem cells self-renewal/differentiation, as shown
by the accumulation of intermediate and terminal differentiation
products (nematoblasts, nematocytes and secretory cells). The
biochemical repression of Hymyc1 activity achieved by using
10058-F4 inhibitor, a disruptor of c-MYC/MAX dimerization,
produced similar effects on Hydra polyps, confirming the specificity
and the validity of our RNAi approach.
The kinetic of Hymyc1 RNAi was also evaluated, together with
the effect displayed on the regenerative capability of the polyp.
Together with the establishment of a reliable loss of function assay
to analyse gene function in Hydra, the specific myc silencing opens
new avenues to decipher the molecular control of the cellular
plasticity underlying growth and proliferation in Hydra, providing
further insights into the complex myc network also in higher
organisms.
Results
Hymyc1 downregulation through siRNA
In a previous study [12] we showed that at acidic pH fluorescent
semiconductor nanoparticles, showing positive surface charge, are
actively internalized by Hydra ectodermal cells, while negatively
charged nanoparticles are not uptaken. With the aim to
downregulate Hydra myc1 gene we tested the possibility to perform
RNA interference mediated by small interfering RNAs. 21 bp long
RNA oligonucleotides with symmetric 2 nt 39 overhangs targeting
the coding region of the Hymyc1 gene (myc-siRNA) were designed
according to specific rules found to enhance the silencing effect of
siRNA [16–18] and chemically synthesized. An estimation of their
surface net charge was achieved by zeta potential measurements, a
method widely used to quantify the electrokinetic potential in
colloidal systems [19]. Zeta potential measurement of siRNA
duplexes as function of pH showed that they present positive net
charge at pH 4 in Hydra culture medium (see Figure S2 of
Supporting Information), while at physiological pH, as expected,
they are negatively charged. The silencing properties of myc-siRNA
were thus tested at pH 4, by soaking the animals in their culture
medium in presence of 70 nM myc-siRNA, a concentration
comparable to that used in other studies of siRNA mediated gene
silencing [20], while lower doses were found ineffective. The use of
Alexa fluor 488 end labelled myc-siRNA enabled us to track in vivo,
by fluorescence microscopy, the capability of naked siRNAs to
cross Hydra cell membranes at pH 4 (Figure 1A–1B), with a greater
efficacy compared to pH 7 (Figure 1C–1D), indicating that the
effective delivery of the siRNA in vivo was enhanced by the acidic
condition. Analysis of single cell suspensions shows delivery of
labelled myc-siRNA to both epitheliomuscular and interstitial cells
(Figure 1H–1M), while confocal microscopy analysis confirmed
the localization within nests of nematoblasts (Figure 1E–1G),
where Hymyc1 is expressed. The silencing effect was evaluated at
molecular level by quantitative Real Time PCR (qRT-PCR).
Treatment with myc-siRNA for two days (2 d) caused a significant
reduction of Hymyc1 transcript levels at pH 4, but not at pH 7
(Figure 2A) suggesting that enhanced acidic-mediated uptake of
RNA duplexes is required to induce specific gene silencing. The
post-transcriptional silencing induced by myc-siRNA was con-
firmed at protein level by Western Blot analysis. Following
preliminary semi-quantitative RT-PCR analysis (Figure 2B, upper
panel), polyclonal antibodies raised in rabbit against HyMYC1
recombinant protein detected a drastic decrease of HyMYC1
protein in myc-siRNA treated animals by 2 d, compared to
endogenous levels of Hydra actin (Figure 2B, lower panel). The
specificity of the RNAi approach was assessed by testing unrelated
siRNAs, such as Luciferase siRNA (luc-siRNA), designed on the
firefly luciferase GL2 gene. Results showed that Hymyc1 transcrip-
tion and translation were unaffected in luc-siRNA treated animals
(Figure 2B). By qRT-PCR the potential adverse effects played by
the acidic pH on gene expression were also analysed. As it might
be argued that the acidic condition could play adverse effects on
gene expression, we analysed the endogenous Hymyc1 expression
level in animals incubated at pH 4 for increasing periods, and
compared them to expression levels in physiological condition
(pH 7). The graph of Figure S3-A (Supporting Information) shows
similar levels of Hymyc1 transcripts both at pH 4 and pH 7,
indicating that Hymyc1 endogenous expression was unaffected by
the acidic environment. Morphological analysis of treated animals
further confirmed the absence of adverse effects played by the low
pH on polyp viability (Figure S3-B of Supporting Information).
The efficiency of RNAi as function of the duration of treatment
is shown in Figure 2C. Specific gene inhibition was detected in
myc-siRNA treated animals by 2 d of treatment, when a 60%
decrease in the Hymyc1 mRNA amount was measured. Increasing
the period of treatment up to 9 d did not further increase the
silencing efficiency, probably due to fast cell turnover of the
interstitial stem cells, continuously replacing the interfered cells or
to the animal adaptation to the treatment. The long lasting effect
of the RNAi was then investigated by performing a 4 d RNAi
treatment followed by RNAi suspension and culturing in
physiological condition, under normal feeding regime, over
different periods. The graph of Figure 2D shows that Hydra
polyps could recover from the RNAi treatment, restoring
physiological levels of Hymyc1 transcripts over the following five
days. Thus the observed downregulation depends upon the
continuous presence of siRNA oligonucleotides and indicates the
reversibility of the siRNA mediated RNAi, similarly to other
invertebrates RNAi knockdown models [21].
The efficiency of the new developed RNAi approach was tested
on an additional gene, b-catenin (b-cat), a key gene involved in
Hymyc1 Silencing Using siRNA
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containing protein expressed weakly and uniformly throughout the
polyp and at higher level in developing buds [22–23]. Hydra polyps
treated for 2 d with specifically designed b-cat-siRNA revealed a
strong and significant reduction (more than 50%) of the target
mRNA (Figure S4), confirming the validity and the reproducibility
of our RNAi strategy.
Hymyc1 gene silencing promotes proliferation of single
and pairs of interstitial stem cells
In order to detect differences in the expression pattern of myc-
siRNA interfered animals whole mount in situ hybridizations using
a Digoxigenin-labelled Hymyc1 RNA probe were performed.
Despite the decreased Hymyc1 expression detected by qRT-PCR,
differences in the signal distribution pattern between healthy and
interfered animals (analysed at 2 d, 4 d and 9 d of continuous
siRNA treatment) could not be appreciated, due to the
Digoxigenin detection technique, not allowing quantitative
measurements. As shown by stained specimens both whole
mounted and cryo-sectioned (Figure 3A–3D) Hymyc1 residual
transcripts were detected in myc-siRNA treated animals in single
and pairs of interstitial cells (1 s, 2 s), nests of nematoblasts
(4 s216 s), accordingly to previous reports [10]. The same
expression pattern was detected in luc-siRNA treated animals,
confirming the absence of aspecific effects due to the siRNA
treatment (data not shown). A quantitative evaluation of the
Hymyc1 positive cells confirmed the absence of significant
differences between interfered (by myc-siRNA and luc-siRNA)
and control animals (Figure S5). This result suggests that the
activation of the RNAi machinery occurred throughout the
targeted cells, rather than on limited patches of cells where the
siRNA could be selectively delivered.
Since the multipotent interstitial cells, their differentiation
intermediates, and their product cells are all closely related
(Figure 3E), changes in their relative population sizes may yield
clues as to how these populations are controlled. A morphological
analysis both at cellular level and in intact animals was then
performed to investigate potential effects induced by Hymyc1
Figure 1. In vivo RNAi mediated by siRNA. Fluorescence imaging of Hydra vulgaris exposed to myc-siRNA at different pHs. Living polyps were
challenged with 70 nM Alexa488-end labelled myc-siRNA, in Hydra medium either at pH 4 (A, B) or at pH 7 (C, D). After 24 hr of continuous
incubation with siRNA a strong punctuated fluorescence labels uniformly the whole animal, from the head (A) along the body (B) of animals treated
at acidic pH, indicating the uptake of siRNA. In (C) and (D) are shown the body regions corresponding to A and B, respectively, of animals treated with
the same siRNA at neutral pH. The absence of fluorescence signals indicates that the acidic pH enhances siRNA delivery in Hydra. Scale bar 200 mm.
Confocal laser scanning imaging (E–G) of living Hydra treated 24 hr with Alexa488-labelled myc-siRNA revealed localization of oligonucleotides into
interstitial cells. In (E), nuclear staining of interstitial cell nest with TOPO3; in (F) siRNA green fluorescence appears as faint staining or more evident
granules; in (G), the overlay of bright field and fluorescence images revealed that siRNAs localize prevalently into the cytoplasm of interstitial cells.
Scale bars: 10 mm. Fluorescence microscopy analysis of single cells suspensions prepared from treated dissociated animals shows intracellular
localization of siRNA into interstitial (H) and epitheliomuscular (I) cells, as a punctuated pattern. The same cells were observed by phase contrast
microscopy, respectively in (L) and (M). Scale bar 10 mm.
doi:10.1371/journal.pone.0030660.g001
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distribution.
As Hydra epithelial cells proliferate with a cell cycle of about
3,5 d [24–25] and interstitial cells much faster with a cell cycle of
about 1 d [26], the cycling activity of the epithelial and interstitial
cells was assayed by continuous BrdU-labeling, over 3 and 2 d,
respectively. Figure 4A shows that the proliferation rate of
epithelial cells was not affected by myc RNAi, thus this cell type
could be used to normalize relative cell type distribution. By
contrast, proliferation of single and pairs of interstitial cells
(1 s+2 s) was enhanced in myc-RNAi animals, indicating an effect
of myc downregulation on the stem cell cycling activity (Figure 4B).
The estimation of cell proliferation rate by mean of BrdU was
carried out also in differentiating nematoblasts (4 s) and gland
cells. Results reported in Figure S6 showed that Hymyc1 RNAi
does not affect proliferation rate of these cell types, suggesting a
Hymyc1 role played specifically on 1 s+2 s cells.
To gain insight into the possible effects of Hymyc1 RNAi on the
cell cycle, mitotic index and DNA content of 1 s+2 s cells were
assessed. Counts of DAPI-stained cells by phase contrast
microscopy combined with nuclear DNA staining revealed that
the fractions of cells undergoing mitosis in myc-siRNA treated
animals were 3,7% and 3,4% upon 3 and 4 d of treatment,
respectively (n=1000, for each treatment). Conversely, these
fractions in untreated animals were 2,7% and 2,3% after 3 d and
4 d, respectively, indicating an increase of more than 40% of the
mitotic index of 1 s+2 s cells as effect of RNAi. To check whether
or not Hymyc1 silencing controls specific cell cycle checkpoints, the
DNA content of 1 s+2 s cells from RNAi animals was determined.
We found not significant differences in the nuclear DNA profile
between untreated and Hymyc1 RNAi animals, suggesting that
Hymyc1 does not act as a regulator of one specific cell cycle
checkpoint (Figure S7 of Supporting Information).
To investigate the effects of Hymyc1 downregulation on all
interstitial cell lineage, cell type distribution was analysed in
macerates at two time points, 4 d and 9 d, and the cells counted
relative to epithelial cells, as not affected by Hymyc1 RNAi
(Figure 4A). After 4 d of siRNA treatment, the observed increased
ratio 1 s+2 s/EPI was consistent with the boost of mitotic index
and BrdU labelling previously reported (see above text and
Figure 4B). Furthermore, we found in myc-siRNA treated animals
an increase in the population of nematoblasts (4 s216 s), zymogen
and mucous cells, more pronounced at 9 d (Figure 4C, 4D), while
nerve cells were not affected, suggesting a Hymyc1 specific role in
nematocyte and gland cell differentiation pathways. The popula-
tion of mature nematocytes embedded in the battery cells was
analysed in tentacles of intact fixed animals. Hydra tentacles are
structured as cell bilayers, as the rest of the animal body, but
Figure 2. Molecular characterization of Hymyc1 RNAi. (A) quantitative RT-PCR showing Hymyc1 downregulation enhanced by acidic condition.
Animals treated by myc-siRNA at pH 4 showed 60% decrease in Hymyc1 transcription levels compared to Hydra Elongation factor HyEF1a mRNA, used
as internal control (two asterisks, p,0.01 according to t-Student test). (B) Upper panel: semi-quantitative RT-PCR showing Hymyc1 downregulation
induced specifically by myc-siRNA (lane myc) and not by luc-siRNA (lane luc), or in untreated animals (lane C) used as controls. Lower panel: Hymyc1
RNAi affects also MYC protein levels. Lane labels are as in the upper panel. MYC protein levels were detected using anti-HyMYC1 antibody (1:500,
kindly provided by K.Bister, University of Innsbruck) and compared to actin proteins, using an anti-actin primary antibody (1:100, Sigma) to probe an
identical blotted gel. HyMYC1 shows an apparent mol. weight of 35 kDa, as elsewhere reported [10]. (C) Kinetics of Hymyc1 downregulation. qRT-PCR
was performed on total RNA extracted from 25 animals either untreated (namely incubated at pH 4, in absence of siRNA) or incubated with the
indicated siRNA for different periods. The most effective downregulation is detected at the beginning of the treatment, and it is specifically induced
by myc- and not luc-siRNA duplexes (two asterisks, p,0.01 according to t-Student test). (D) Reversible effect of RNAi. Animals were treated with myc-
siRNA for 4 d (time t=0) and then cultured in physiological condition for the indicated periods of time (3 days, 5 days), when total RNAs were
extracted for qRT-PCR analysis. Suspension of RNAi treatment restored in five days myc mRNA transcript levels up to physiological values. Error bars in
A, C and D indicate standard deviations calculated from three independent experiments, each performed in triplicate.
doi:10.1371/journal.pone.0030660.g002
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[27–28]. These tentacle specific cells arise from terminal
differentiation of ectodermal cells, including the mitosis arrest
and the inclusion into the cytoplasm of neuronal cells and several
nematocytes, the stinging cells involved into the prey capture. This
complex system, the battery cell, is recognizable by phase contrast
optical microscopy. Results of Figure 5A show that myc-siRNA
interfered animals, both at 4 d and 9 d, presented an increased
ratio of mature nematocytes/battery cells, compared to relative
control sets of animals and a representative battery cell is reported
in Figure 5B. This effect was induced by myc-siRNA treatment in
almost all individuals, as shown by the distribution of the ratios
among ten animals (Figure S8).
The specificity of the phenotype induced by myc-siRNAi was
tested by treating animals with a biochemical c-MYC inhibitor,
the thioxothiazolidinone10058-F4 [29], which blocks c-MYC/
MAX heterodimer formation through molecular mechanisms
poorly understood so far, and it affects as well the myc gene
transcription level [30–31]. Treatment of living polyps with 10058-
F4 for 2 d induced 50% reduction of Hymyc1 expression levels, as
assayed by qRT-PCR (Figure 6A), while analysis of cell
proliferation rate showed an effect on 1 s+2 s cells (Figure 6B),
but not on other cell types (Figure S6 of Supporting Information).
Cell type distribution analysis also revealed increased proliferation
of 1 s+2 s stem cells, and increased amounts of intermediates and
terminal differentiation products (nematoblasts, nematocytes,
secretory cells) (Figure 6C). As detected in Hymyc1 RNAi polyps,
also the phenotype of the battery cells was affected, containing an
abnormal number of nematocytes (Figure 6D), indicating
unequivocally the specificity of the Hymyc1 downregulation effects,
and indirectly the structural and functional conservation of the
HyMYC1/HyMAX complex. Taken together, these findings
suggest that genetic and biochemical repression of Hymyc1 activity
affects in the same way the interstitial cell lineage homeostasis:
Hymyc1 conditional elimination enhanced stem cell proliferation,
and in turn unbalances the differentiating products.
As Hymyc1 is expressed in proliferating stem cells of the
interstitial cell lineage, we also evaluated its expression profile
during regeneration, a complex phenomena involving extensive
cell reprogramming, proliferation and differentiation processes to
rebuild a new organism from an amputated moiety [32].
Quantitative analysis of Hymyc1 expression performed over the
first 24 h post amputation indicates that Hymyc1 expression levels
were not specifically modulated during the early stages of the
regenerative process of healthy animals (Figure 7A). When
analysing myc RNAi regenerating animals, similar Hymyc1
expression levels were found (Figure 7B) indicating that the RNAi
effect was maintained during the regeneration and it could
Figure 3. Hymyc1 expression pattern is not affected by Hymyc1 downregulation. A comparison of whole mount in situ hybridization
performed on A) healthy animals and B) myc-siRNA treated animals (2 d) shows residual Hymyc1 transcripts in the RNAi targeted cells. As previously
reported [10] Hymyc1 is expressed in proliferating interstitial cells, distributed along the gastric region, shown at higher magnification in (C). A cross
section of stained animals confirms this expression pattern (D). Scale bars: 1 mm in A and B; 200 mm in C and D. A scheme of the differentiation
pathways in the interstitial stem cell system is shown in (E). Interstitial stem cells include multipotent stem cells (1 s) and committed stem cells (2 s)
that differentiate three major cell types in Hydra (nematoblasts, secretory cells, neurons, and gametes). Nematocytes, the phylum representative cells
arming the tentacles and used for pray capture, originate from nematoblasts, i.e. committed cells that after several mitotic divisions (generating nests
of 4, 8 and 16 cells connected by cytoplasmic bridges) finally differentiates into several types of nematocytes (stenoteles, desmonemes, isorriza,
depending on the nematocyst morphology). 2 s cells committed toward either nematocyte, nerve or secretory cells, are morphologically
indistinguishable. While single interstitial stem cells (1 s) continuously self renew, among the daughter cells (2 s) 60% remain stem cells, whereas 40%
become committed to different cell types.
doi:10.1371/journal.pone.0030660.g003
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the regenerating animals was analysed in more detail. In situ
hybridization on Hymyc1 interfered regenerating animals, similarly
to what observed on intact animals, did not reveal quantitative
differences in the Hymyc1 expression pattern (data not shown),
while a clear morphological phenotype was detected in the
regenerated tentacles: the average tentacle length and nematocyte
content per battery cells were significantly increased (Figure 7D–
7F) indicating that Hymyc1 RNAi effect persists throughout the
regenerative process and affects tentacle morphogenesis. These
results substantiate the view of a role of Hymyc1 in the control of
proliferation/differentiation rate in Hydra.
Discussion
The possibility to perform gain- or loss- of function approaches
to analyse gene function may add new values to the widespread
use of Hydra as a genomic model organism with a pivotal position
in the evolutionary tree. The generation of transgenic polyps by
embryo microinjection is a well-established technique [33] and
several methods have been successfully used to do RNAi in adults.
The published RNAi methods rely on long dsRNA delivered
through different techniques, spanning from whole animal
electroporation [13] to localized electroporation [15], and used
successfully for functional analysis of genes involved in head
regeneration [15–34–35]. In order to reduce major side effects as
tissue necrosis and lethality, a milder strategy for dsRNA delivery
through feeding of dsRNA producing bacteria has been developed
and used for silencing of both endodermal and ectodermal
expressed genes [36–37], while the soaking method using long
dsRNA has been employed for efficient RNAi of key develop-
mental genes in the marine hydroid Hydractinia echinata [38]. We
developed in this paper a novel approach of RNAi in Hydra, based
on siRNA oligonucleotides. First discovered in plants and in the
nematode Caenorhabditis elegans [16–39–40] the production of
siRNAs that bind to and induce also systemically [41] the
degradation of specific endogenous mRNAs is now widely
employed to inhibit gene function and holds great potentials in
the therapeutic treatment of several diseases [42–44]. At cellular
level, duplex siRNAs are negatively charged polymers and so
cannot easily penetrate hydrophobic cellular membranes without
assisting carriers such as cationic polymers, liposomes or
nanoparticles. We succeeded in our delivering method by working
in acidic conditions, which resulted in siRNA charge reversal and
great enhancement of siRNA intracellular delivery. Alexa 488
labelled myc-siRNAs were found into the cytoplasm of Hydra
ectodermal cells, within both epitheliomuscular and interstitial
cells, as granular structures with different sizes, not excluding the
presence of single units, undetectable by confocal microscopy
analysis (Figure 1). The experimental conditions used for siRNA
delivery confirm previous data on the importance of the positive
surface charge of delivery vehicles in promoting cell uptake [12–
45–46]. In Drosophila an active and specific pathway that involves
clathrin-mediated endocytosis has been found responsible for
Figure 4. Effect of myc RNAi on cell cycling activity and cell type distribution. Cell cycling activity of epithelial cells (A) and 1 s+2 s stem
cells (B) were obtained in control and treated animals by continuous incubation with BrdU, followed by maceration of ten animals at the indicated
time points and fluorescence immunostaining. Data represent the average of three different experiments. In (C) and (D) the distribution of different
cell types was assayed after 4 d and 9 d of myc RNAi, respectively. Five test animals were randomly selected from a pool of twenty five treated
animals, and macerated for cell counting. The data represent the average of five independent RNAi experiments. Bars indicate standard errors.
1s +2 s=single and pairs of interstitial cells; nematoblasts=nests of 4 s216 s proliferating and differentiating nematoblasts; EPI=epithelial cells.
doi:10.1371/journal.pone.0030660.g004
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mechanism of cytoplasmic release to enter the RNAi machinery
has not been identified to date. Although it might be argued that
by our approach siRNA delivery occurs more into ectodermal cells
rather than into interstitial cells, the strong molecular downreg-
ulation observed suggests that the RNAi response results from
both direct delivery to interstitial cells and spreading effect of the
RNAi response, similarly to other invertebrates [41–47]. This
hypothesis is supported by the presence in the Hydra genome of
predicted genes encoding for components required for amplifica-
tion and systemic spread of an RNAi signal, i.e. RNA-dependent
RNA polymerase (RdRP) and SID proteins (Hma1.117083 and
Hma1.114101 respectively). Moreover, the cytoplasmic bridges
present among nematoblasts might provide direct passage of
siRNA signals through connected cells to enable RNAi. We
targeted our RNAi approach to Hymyc1 gene and showed the
specificity of our method including luciferase- and b-catenin-
siRNA as negative and positive controls, respectively. While b-cat
silencing proved the robustness and reproducibility of our RNAi
method, luc-siRNA ineffectiveness in Hymyc1 downregulation
demonstrated the absence of harmful sequence independent side
effects elicited by the siRNA treatment: phenotypical, cellular and
molecular analysis showed that luc-siRNA did not alter Hymyc1
expression, nor interfered with proliferative/differentiating pro-
cesses leading to abnormal phenotypes.
Hymyc1 is homologue of the c-myc protooncogene, a key gene
conserved throughout the animal kingdom [48], controlling
several fundamental processes of the cell cycle, both intracellular
functions (cell growth, proliferation, apoptosis) and extracellular
processes that coordinate cell proliferation with the microenvi-
ronment (the stem cell niche) [49]. Although the molecular,
biochemical and functional analyses of Hymyc1 has highlighted
structural conservation in the featuring domains (i.e. bHLH-Zip
domain and myc-boxes I to III) and functional similarities to the
vertebrate derivatives [10], its physiological role in Hydra has not
been elucidated so far. By challenging living Hydra with myc-
siRNAs, we specifically downregulated Hymyc1 mRNA and
protein levels. The inhibition was achieved after 2 d of treatment,
while continuous incubation up to 9 d, under normal feeding
regime, did not cause cumulative effects, probably due to
saturation of the RNAi machinery, or to other mechanisms of
animal adaptation. Our experimental conditions ensured animal
health all along the treatment period and the absence of stressing
condition (such as starvation or chemical/physical compounds
required for efficient delivery of nucleic acids), which can
complicate the interpretation of the phenotypical effect of gene
silencing. Despite the presence of an additional myc orthologue
gene in the Hydra genome database (Hymyc2) which could possibly
interfere with Hymyc1 downregulation, a clear phenotypical effect
was detected in myc-siRNA treated animals. At cellular level, an
extensive analysis of single cells prepared by maceration revealed
abnormal distribution ratios between cellular types of the
interstitial cell lineage. As the density of the stem cell population
(i.e 1 s+2 s/EPI) is species-specific and dependent upon environ-
Figure 5. Hymyc1 RNAi induces an increase in the nematocyte content of battery cells. (A) At time 4 d and 9 d of treatment with the
indicated siRNA, animals were fixed and the number of nematocytes embedded in the battery cells, observed under the same focus plane, was
scored. Data represent the average of measures from ten animals 6 standard deviation. (B) Representative battery cells imaged from normal (left),
myc-siRNA (middle) and luc-siRNA (right) treated animals, on whole mounts. Hand drawn black lines indicate the battery cell membranes. Hymyc1
downregulation induces nematocyte differentiation and accumulation into battery cells. Scale bar: 20 mm.
doi:10.1371/journal.pone.0030660.g005
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report the absolute values, but pointed out to their changes
relatively to control animals. While not affecting the epithelial cell
proliferation rate, Hymyc1 downregulation induced a moderate
increase in the stem cell proliferation rate and density, which
produced dramatic effects on the related cell population sizes.
These results are in line with previous studies relating stem cell
self-renewal to the cell density, and showing that nematocyte
commitment increases as stem cell concentration increases [[5–
24–26]. The abnormal numbers of mature nematocytes embedded
in the tentacle battery cells confirmed the burst in the nematocyte
differentiation. Although we cannot exclude an effect on nerve cell
commitment, the measure of mature nerve cells, found unaffected
by Hymyc1 repression, ruled out an enhancement in nerve cell
differentiation. By contrast, the secretory cell differentiation
pathway was profoundly activated, as shown by the doubled
numbers of both zymogen and mucous cells. Interestingly, at 9 d
of treatment, the stem cell density was restored to physiological
levels, suggesting a negative feedback between stem cells, as
elsewhere proposed [6]. The specificity of the effects produced by
Hymyc1 inhibition was confirmed using a chemical inhibitor of the
MYC/MAX interaction, 10058-F4 [29]. Treatment of living
polyps with this inhibitor induced Hymyc1 downregulation, as well
as increased 1 s+2 s stem cell proliferation and enhanced
differentiation of nematoblasts, secretory cells and nematocytes.
A schematic model of the effects of both the genetic and
biochemical Hymyc1 inhibition on the proliferation/differentiation
rates is shown in Figure 8. Altogether these results suggest a role of
Hymyc1 in the negative regulation of the stem cells where it is
expressed: the decreased expression enhances stem cell prolifer-
ation and in turn the differentiation of intermediates and terminal
derivatives. The increase in stem cell density may finally inhibit the
stem cell self-renewal capability over long periods.
Of intriguing interest is the effect displayed by Hymyc1 RNAi
on Hydra regeneration. qRT-PCR showed that, 24 h post
amputation Hymyc1 transcription levels are similar to pre-
amputation. Regenerated heads also presented morphological
traits similar to the pre-amputated animals, i.e longer tentacles
armed with an abnormal number of nematocytes, suggesting the
persistence of the RNAi response. Consistent with this hypothesis
are evidences from C.elegans, in which effective interference is
observed in the progeny of dsRNA injected animals at early larval
stages [21], and from the planarian flatworm Schmidtea mediterra-
nea, where gene inhibition persists throughout the process of
regeneration [50].
The involvement of c-myc in controlling cell proliferation and
differentiation processes has been shown in several systems, by
both gain and loss of function approaches. In murine hematopoi-
etic stem cells (HSC) the group of Trumpp showed that c-myc
conditional elimination resulted in the accumulation of HSCs in
Figure 6. Molecular and morphological alteration induced by the c-myc inhibitor 10058-F4. A) Living polyps were treated with the c-myc
inhibitor 10058-F4 for 48 h at two different concentrations (30 mM and 90 mM) before RNA extraction for qRT-PCR analysis. Expression levels, relative
to HyEF1a, indicate Hymyc1 silencing in a dose dependent manner, reaching 47% downregulation at the higher dose tested. Error bars indicate
standard deviations calculated from three independent experiments, each performed in triplicate. B) Cell cycling activity of 1 s+2 s stem cells were
obtained in control and treated animals (as above, 10058-F4 90 mM) by continuous incubation with BrdU, followed by maceration of ten animals at
the indicated time points and fluorescence immunostaining. Labelling indexes of 4 s and gland cells are reported in Figure S6 of Supporting
Information. C) Single cell suspensions were prepared from polyps treated as in A and the relative cell types counted by phase contrast microscopy.
Treatment with 10058-F4 enhances stem cell proliferation and determinates the accumulation of intermediate and terminal differentiation products.
D) Polyps treated with the c-myc inhibitor as in A were fixed and whole mounted for analysis of the nematocyte content into the tentacles (as
described in Figure 5). The small molecule myc inhibitor induces an increase in the nematocyte content of battery cells, identical to the effect induced
by myc-siRNA.
doi:10.1371/journal.pone.0030660.g006
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[51–52]. In human pancreatic endocrine cell lines c-myc down-
regulation by RNAi induces cells to exit the cell cycle and enter the
differentiation pathway, thus c-myc plays a role in the switch
mechanism that controls the inverse relationship between
proliferation and differentiation [53]. In Drosophila mutation of
the Drosophila myc gene results in small flies due not to fewer cells
but to their cells which are smaller in size [54], suggesting that dmyc
participates in the regulation of cell mass. Although myc and the
members of the myc ‘‘network’’ are encoded in the genomes of
most metazoan phyla and many aspects of its biology may arise
from comparative analysis, the disparate cellular events seeing its
involvement make it difficult to evaluate myc’s function in its
entirety due to redundancy among family members, tissue
specificity, and complex phenotypes.
In Cnidaria, the molecular mechanism underlying RNAi have
not been elucidated so far. We show the capability of siRNA to
enter Hydra cells and to trigger a RNAi response, similarly to many
metazoans. Many other aspects of the Hydra RNAi response need
to be addressed now, from the systemic long range character of the
RNAi response, to the mechanisms underlying the uptake of
siRNA, to the deviation from standard endocytic uptake at some
Figure 7. Effect of Hymyc1 RNAi on regeneration. A) Healthy animals were bisected at time t=0 and allowed to regenerate for the indicated
period, expressed in hours. At different times post amputation (p.a.) total RNA was extracted and analysed by qRT-PCR. Not significant differences in
Hymyc1 expression levels were detected during the regenerative process. B) myc-siRNA treatment (4 d) caused a reduction of myc mRNA levels. At
this point (time t=0) animals were bisected and allowed to regenerate for the indicated hours. Downregulation effects persist during regeneration.
Each error bar indicates standard deviation calculated from triplicates. C–D) myc-siRNA treated animal present abnormal tentacle morphogenesis.
Representative phenotypes of head regeneration at 72 hr post amputation are shown. A myc-siRNA treated animal (D) presents tentacles of increased
length compared to untreated (C) or luc-siRNA treated polyps (not shown). Scale bars: 500 mm. E) The average of tentacle length, calculated on a
subset of 20 animals/condition, indicates the faster tentacle development induced by myc-RNAi. Asterisk indicates p,0,05, according to t-Student
test). F) The average nematocyte content of the battery cells was scored on tentacles of regenerating animals at 96 hr post amputation. myc-RNAi
promotes nematocyte differentiation.
doi:10.1371/journal.pone.0030660.g007
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model of RNAi. The current design in our group of nanocarriers
to improve siRNA delivery, self-tracking and specificity will surely
provide in the near future new tools to decipher the mechanisms of
RNA interference in Hydra.
In conclusion, this study focuses on Hymyc1 silencing, through
an innovative RNAi strategy enhancing siRNA uptake in the
polyp, and describes how Hymyc1 knockdown affects the
developmental dynamics of stem and interstitial cell lineage in
Hydra. In particular, our results add significant value to
fundamental studies on the stem cell biology addressing the
mechanisms by which these cells maintain the balance between
self-renewal and differentiation. As myc deregulated expression
occurs in the majority of human cancers, understanding the
ancient roots of myc biology may be of interest for the wide
scientific community targeting c-myc for therapeutic purposes. For
scientists working on cnidarians this paper opens new avenues to
decipher the molecular control of the cellular plasticity underlying
growth and proliferation in Hydra.
Finally, the establishment of a RNAi method which avoids
invasive procedures while ensures effective delivery of siRNA
under normal culturing condition, lays the foundations of a
comprehensive analysis of the RNAi response in Hydra allowing to
track back in the evolution the origin of the RNAi response.
Materials and Methods
Culture of animals and regeneration experiments
Hydra vulgaris (strain Zurich, originally obtained by P.Tardent)
were asexually cultured in Hydra medium (1 mM CaCl2, 0.1 mM
NaHCO3, pH 7) by the method of Loomis and Lenhoff with
minor modifications. The animals were kept at 1861uC and fed
three times per week with freshly hatched Artemia salina nauplii.
Polyps from homogeneous populations, three-weeks-old and
carrying one or two buds, were selected for the experiments. For
regeneration experiments, treated polyps (4 d of treatment) were
bisected in the upper gastric region and monitored at various time
points post amputation.
In vivo RNA interference through small interfering RNAs
For RNA interference groups of 25 animals were collected in
plastic multiwells, allowed to equilibrate at room temperature in
1m lo fHydra medium at pH4. The test was initiated by adding
70 nM siRNA to each well containing the animals, since then
continuously exposed to the siRNA oligonucleotides, under
normal feeding regime. After the washing procedures new siRNA
oligonucleotides were supplied. 21 bp long siRNA targeting
Hymyc1 were designed using on line siRNA design services and
purchased by QIAGEN. Both unlabelled and 39- Alexa fluor 488
Figure 8. Interstitial cell differentiation pathways. Schematic representation of the multiple differentiation pathways of the interstitial stem
cells in homeostatic condition (A) and the effects on stem cell proliferation/differentiation induced by genetic or biochemical Hymyc1
downregulation (B). myc-siRNA treatment or myc biochemical inactivation induce a moderate increase in the 1 s and 2 s stem cell self-renewal and
proliferation activity (red arrows). This in turn generates a higher number of both differentiating intermediates (nematoblasts) and terminal
differentiated products such as nematocytes and gland cells (blue arrows). Dashed arrows indicate the absence of morphological distinct cellular
intermediates. Hymyc1 downregulation does not affect the nerve differentiation pathway, consistent with the absence of Hymyc1 expression in this
cell type.
doi:10.1371/journal.pone.0030660.g008
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AAGATGCTCACGCGTCAAGAA-39. As control of silencing
specificity, siRNA oligonucleotides targeting the Luciferase GL2
gene were purchased by QIAGEN (cat no 1022070). Moreover, as
positive control to assess the reliability of this RNAi method, b-
catenin gene expression was interfered by using a specific 21 bp
long siRNA corresponding to nucleotides 750–770 of Hydra vulgaris
b-catenin mRNA (GenBank Accession no. U38624.1). The myc
inhibitor 10058-F4 (5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thia-
zolidinone) was purchased by Sigma-Aldrich (cat no. F3680).
Groups of 25 animals were incubated for 48 h in presence of
10058-F4 (30 mMo r9 0mM), and then used for molecular and
cellular characterization, as described in the following sections.
Imaging
siRNA uptake was monitored in vivo, using a Camedia-digital
camera (Olympus) connected to a stereomicroscope (Olympus
ZSX-RFL2) equipped with fluorescence filter sets (BP460- 490/
DM505/LP510). Following extensive washes, in vivo imaging was
accomplished by an inverted microscope (Axiovert 100, Ziess)
equipped with a digital colour camera (Olympus, DP70) and
fluorescence filter sets (BP450-490/FT510/LP515). For imaging
acquisition and analysis the software system Cell F (Olympus) was
used. Confocal images were collected with a Leica TCS SP2
AOBS confocal microscope (Mannheim, Germany) with 406oil
immersion optics. Laser lines at 488 nm and 633 nm for excitation
of Alexa fluor 488 and TOPO-ETC were provided by an Ar laser
and a HeNe laser, respectively. Detection ranges were set to
eliminate crosstalk between fluorophores. Tissue imaging of
interfered animals was performed under bright field.
Quantification of in situ hybridization signal for Hymyc1 was
accomplished as it follows: whole mounted animals were imaged
by an inverted microscope (Axiovert 100, Ziess) equipped with a
digital colour camera (Olympus, DP70). Images were taken under
the same conditions of acquisition (light and exposure time), saved
in tagged-image file format (TIFF) at a size of 130061030 pixels,
posterized by Adobe Photoshop by setting the same threshold
levels and then converted in HSB format for data processing using
the Image processing and Analysis software Image J (Version
1.45i).
Gene and protein expression analyses
Whole-mount in situ hybridization using DIG-labelled RNA
probe was carried out as described previously [55] using NBT/
BCIP (Roche) as substrate for staining. The myc riboprobe was
synthesized using the plasmid Hymyc1 (GenBank Accession
no. GQ856263) as template and used at a concentration of
0.1 ng/ml for hybridization. The Hymyc1 plasmid was produced as
described [10].
Total RNAs from treated and untreated animals was purified
using Tri Reagent (Molecular Research Center) and its concen-
tration was quantified on the NanoDrop ND-1000 spectropho-
tometer (Thermo Scientific, USA). The first-strand cDNA
synthesis was carried out with the SuperScript II Retrotranscrip-
tase (Invitrogen) and oligo dTs, using 0.5 mg of DNA-free RNA in
a final volume of 25 ml, according to the manufacturer’s
instructions. Semiquantitative RT-PCR was employed to estimate
myc mRNA levels. Each PCR reaction was carried out with
Platinum Taq DNA Polymerase kit (Invitrogen) in a total volume
of 25 ml containing 1 ml cDNA and 0.5 mM primers for Hymyc1
(forward: AGGACGAAGTTGATGTAGTTGGA; reverse: 59-
GCGAAGCAACTTTCAGTATTGTTAC-39 and Hydra Elonga-
tion factor 1a (59-ATGATTGAACCATCCCCAAA-39;5 9GCT-
TCAATGGCAGGATCATT 39) as reference gene. After initial
denaturating step of 59 at 94uC, cycling steps were as follows: 30 s
at 94uC, 30 s 58uC and 30 s at 72uC. For comparative analysis,
the experiments were done in triplicate and data were collected at
different end point (25, 30 and 35 cycles).
Quantitative Real-Time polymerase chain reaction (qRT-PCR)
was performed in 25 ml of reaction mixture consisting of 16
Platinum SYBR green qPCR SuperMix-UDG with ROX
(Invitrogen), serial cDNA dilutions and 0.5 mM each primer.
The reactions were processed using the StepOne Real-Time PCR
system (Applied Biosystem) under the following cycling steps:
initial denaturation for 10 min at 94uC, followed by 40 cycles at
94uC for 15 s, 58uC for 30 s, and 72uC for 30 s, and a 20 min
gradient from 55uCt o9 0 uC to obtain a melting curve. To
normalize RNA levels, Hydra Elongation factor 1a gene (HyEf-1a
GenBank Accession no. Z68181.1) was employed as internal
calibrator. Gene-specific primers (HyEf-1a: forward, 59CCAG-
GAGACAATGTCGGTTT 39; reverse, 59GCTTCAATGG-
CAGGATCATT 39; Hymyc1: forward, 59 TACAGAAAGC-
GAGGACGAAGTT 39; reverse, 59GCGAAGCAACTTTCA-
GTATTGTTAC 39; b-cat: forward, 59GGCGCTCTTCACA-
TTTTAGC 39; reverse, 59TGCACCTTCACGCTCAATAG 39)
were designed using Primer3 software (http://frodo.wi.mit.edu/
primer3/); the lengths of HyEf-1a and Hymyc1 amplicons were
100 bp and 157 bp, respectively. At least three independent
repeats for each experiment were carried out. Herein, the delta–
delta Ct (2
2DDCT) method, for comparing relative expression
results between treatments, was applied [56].
For Western blot analysis total proteins were extracted from
groups of 25 animals, using the triple detergent buffer according to
Sambrook et al. [57]. The resulting homogenate was centrifuged
for 15 min at 14000 g and the proteins contained into the
supernatants collected and quantified by the Bradford method
using BioRad reagent with BSA as a standard. Equal amounts of
proteins were separated on 12% SDS-polyacrylamide gel and
transferred onto nylon membranes (BioRad, San Diego, CA).
MYC protein levels were detected using anti-HyMYC1 antibody
(1:500, kindly provided by K.Bister, University of Innsbruck) and
compared to actin proteins, using an anti-actin primary antibody
(1:100, Sigma) to probe an identical blotted gel.
Hydra cell and tissue analysis
Analysis of siRNA treated animals was done both on whole
animals and isolated fixed cells. Animals were anaesthetized in 2%
urethane in Hydra medium for 2 min. The relaxed and elongated
Hydra were fixed with Lavdowsky’s fixative (ethanol: formalin:
acetic acid: water-50:10:4:40), rehydrated, and mounted on
microscope slides in Glycerol 50% in PBS (8 g/l NaCl; 0.2 g/l
KCl; 1.44 g/l Na2HPO4.7H20; 0.24 g/l KH2PO4). The tentacles
were examined for two types of nematocyst capsules (stenoteles
and desmonemes) under an optical microscope. The battery cell
structure, indeed, makes it possible to count the nematocytes with
phase optics (326) on the surface of a fixed tentacle facing the
objective. Each tentacle was divided into three ideal sections of
different length from the base to tip, and the number of
nematocytes present in the middle section was counted. The ratio
nematocyte/battery cell was calculated on a total of one hundred
battery cells, collected on ten different polyps. An estimate of the
tentacle length during head regeneration was calculated on images
from both untreated and siRNA treated animals using the Cell F
software (Olympus). At least 25 animals/condition were analysed.
For analysis of cell type distribution whole animals were
macerated into a suspension of fixed single cells as described [58].
Five animals per condition were macerated at the indicated time of
treatment and scored for single and pairs of interstitial cells
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nematoblasts (4 s216 s), zymogen and mucous cells, epithelial
cells (EPI). An average of 300 EPI cells was counted, per condition.
For cell nuclei detection cells were stained with 49,6-diamidino-2-
phenylindole dihydrochloride (DAPI) 0,25 mg/L before mount-
ing. For analysis of proliferation rates, intact Hydra, untreated or
treated for 48 hr with myc-siRNA, were continuously incubated
with bromodeoxyuridine (BrdU) 5 mmol/l (Sigma) for 1, 12, 24,
48 and 72 hr, immediately fixed, and macerated cells spread on
microscope slides as above described. BrdU incorporation in
proliferating cells was detected by immunolocalization using
mouse anti BrdU monoclonal antibody (1:500, Sigma), and
Novolink Polymer detection System (Novocastra Laboratories
ltd.). To further estimate cell proliferation, mitotic index was
measured on macerates through phase contrast optical microscopy
combined with Hoechst 33342 staining of nuclear DNA by
counting the percentage of cells undergoing mitosis (n=1000 cells
for each treatment). To quantify cell cycle distribution, DNA
content profiles were determined on Hoechst 33342-stained
macerates. Fluorescence intensity of individual nuclei was
quantified by using the Fiji program from ImageJ software
package.
For tissue sectioning, test animals were soaked over night in
30% sucrose in PBS and then embedded in the frozen section
medium Neg-50 (Richard-Allan Scientific). Cryo-sections of
10 mm thickness were obtained by a cryostat (Leitz, digital
1760), collected on gelatine coated slides (Superfrost microscope
slides, Menzel) and mounted in D.P.X (Sigma) before imaging.
Statistical analysis
Tentacle length measurements, number of nematocyte per
battery cell, relative cell type counting and qRT-PCR results were
expressed as means6SD. The statistical significance of the results
was determined by analysis of Student’s t test. p values of ,0.01
were considered highly statistically significant (two asterisks). p
values of ,0.05 were considered statistically significant (one
asterisk).
Supporting Information
Figure S1 Structural anatomy of Hydra vulgaris. a)
Picture of living Hydra. The animal has a simple body plan: it is
a tube with a head at the apical end, and a foot, or basal disc at the
other. The head is in two parts, the hypostome (mouth) at the
apex, and below that the tentacle zone from which a ring of
tentacles emerge. Scale bar 200 mm b) the bilayered structure of
the animal: the body wall is composed of two self renewing cell
layers, an outer ectoderm and an inner endoderm, separated by an
extracellular matrix, the mesoglea. The arrows on the left side
indicate the direction of tissue displacement c) longitudinal sections
at level of tentacle (upper figure) and gastric region (lower figure).
On the tentacle, the ectodermal cells (ec) are called battery cells
and contain embedded several types of nematocytes (nem), one
sensory neuron facing the exterior (sn), a ganglial neuron (gn)
making connections both with other cells and to myonemes. Along
the animal body both ectoderm and endoderm layers are
composed of epitheliomuscular cells, while interstitial stem cells
and their intermediate and terminal derivatives (neurons,
nematocytes and secretory cells) are interspersed among ectoderm
and endoderm.
(TIF)
Figure S2 Zeta potential of siRNA as a function of pH.
The zeta potential of siRNA depends on the pH of the solution:
while at neutral pH siRNA show negative zeta potential values due
to the presence of phosphate groups of the RNA backbone, at
acidic pH, in Hydra culture medium, the presence of calcium
divalent ions neutralize the negative charges, conferring a positive
net charge to the molecules. The positive charge influences the
electrokinetics of the siRNA molecules, promoting their intracel-
lular uptake. Measurements were performed in Hydra medium, at
the indicated pH.
(EPS)
Figure S3 Acidic pH does not affect Hymyc1 expression
levels. A) Endogenous Hymyc1 expression levels were measured
by qRT-PCR on animals kept for the indicated periods at neutral
or acidic pH. Not significant differences were induced by the
different conditions. Data are mean of three independent
experiments. B) Image of a representative polyp incubated at in
Hydra medium at pH 4 for 4 days. The polyp appears healthy,
with long extended tentacles and presents no signs of toxicity
induced by the treatment.
(EPS)
Figure S4 Efficient silencing of b-catenin gene through
siRNA mediated RNAi. qRT-PCR was performed on total
RNA extracted from polyps treated 2 d with Hydra b-catenin
specific siRNA. A significant reduction of the Hyb-cat transcript
levels (60%), compared to HyEF1a, was induced by Hyb-cat
siRNA, showing the reliability and robustness of our approach.
Two asterisks, p,0.01, according to t-Student test.
(TIF)
Figure S5 Quantification of in situ hybridization signal
for Hymyc1 mRNA. The Image processing and Analysis
software Image J (Version 1.45i) was used to quantify the signal
intensity produced by in situ hybridization in control, myc-siRNA
and luc-siRNA treated animals, using Hymyc1 as probe. Not
significant differences were detected as effect of siRNA treatment,
indicating residual Hymyc1 transcripts in myc-RNAi animals. On
the other side, luc-siRNA animals were not affected in Hymyc1
expression, confirming the absence of putative side effects.
(TIF)
Figure S6 Effect of Hymyc1 RNAi on nematoblast and
gland cell proliferation. Cell cycling activity of A) nemato-
blasts (4 s) and B) gland cells. Control untreated animals
(incubated at pH 4) and myc-siRNA treated animals were
continuously incubated with BrdU (red line) and with the c-myc
inhibitor 10058-F4 (90 mM, green line), before maceration at the
indicated time points and fluorescence immunostaining. Data
represent the average of three different experiments. Not
significant differences were observed in the proliferation rates of
4 s and gland cells induced by myc-siRNA or 10058-F4 treatments.
(TIF)
Figure S7 Nuclear DNA content of interstitial stem cells
(1 s+2s )i nmyc-siRNA treated Hydra. A) Hoechst 33342
staining and B) phase contrast image of macerated cells. 1 s and
2 s: large interstitial stem cells (note that 1 s is in mitosis); ecto:
ectodermal epithelial cell; endo: endodermal epithelial cell; gc:
gland cell. C) After three or four days of siRNA treatment, the
nuclear DNA profile of 1 s+2 s shows no significant differences as
compared with untreated polyps. Nuclei of 25 nerve cells and
differentiated nematocytes, which are terminally arrested in G1,
were used to determine the fluorescence intensity of the 2C DNA
content. Procedures: Polyps were treated for three or four days
with myc- siRNA. Then, treated and untreated animals were
macerated and spread onto microscope slides. After drying, the
maceration preparations were stained with Hoechst 33342.
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using the Fiji program of the ImageJ software package.
(TIF)
Figure S8 Distribution of the ratio nematocyte/battery
cells among different animals. At time 4 d and 9 d of
treatment with the indicated siRNA, animals were fixed and
examined under an optical microscope. Under fixed focus plane,
the ratio nematocyte/battery cell was calculated on a total of one
hundred battery cells, collected on ten different polyps. myc-siRNA
specifically induces an increase in the nematocytes embedded in
the tentacle battery cells.
(TIF)
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